当前位置: 首页 >> 检索结果
共有 38879 条符合本次的查询结果, 用时 3.8467402 秒

41. How I do it: Calcium and vitamin D supplements in patients with sarcoidosis.

作者: Patompong Ungprasert.;Sarah F Keller.;Daniel A Culver.
来源: Chest. 2026年
Dysregulated calcium and vitamin D metabolism poses unique challenges for clinicians caring for patients with sarcoidosis. These patients often require supplementation to support their metabolic bone health, yet such interventions may theoretically increase the risk of hypercalcemia and hypercalciuria, along with their associated complications. This article presents four clinical vignettes that illustrate common dilemmas encountered in managing these patients.

42. Chest Radiograph-Derived Age Acceleration as an Early Marker of Pulmonary Dysfunction in Middle-Aged Asians.

作者: Hyungjin Kim.;Yoosoo Chang.;Soon Ho Yoon.;Seungho Ryu.
来源: Chest. 2026年
Deep learning-derived, chest radiographic (CXR) age may capture subclinical structural changes associated with spirometric impairment.

43. Smoking-Related Comorbidities Detected Through Low-dose CT Lung Cancer Screening: Current Evidence and Future Directions.

作者: Marie-Pierre Revel.;Jin Mo Goo.;Rozemarijn Vliegenthart.;Mario Silva.;Annemiek Snoeckx.
来源: Chest. 2026年
Low-dose computed tomography (LDCT) has been established in the past decade as an important and effective tool for lung cancer screening (LCS) in high-risk individuals, with large trials demonstrating significant lung cancer mortality reduction. Beyond pulmonary nodules, LDCT frequently detects a range of smoking-related additional findings, including emphysema, coronary artery calcium, interstitial lung abnormalities (ILA), osteoporosis, and sarcopenia. Accordingly, here we review current evidence on the prevalence, prognostic value, and clinical implications of such smoking-related findings in LCS, with a focus on the findings themselves, their relevance in COPD patients, emerging technologies and future directions for integration into screening protocols.

44. Characterization of CT-Derived Pulmonary Vascular Abnormalities Associated with Pulmonary Hypertension in Chronic Lung Disease.

作者: Agustín R Garcia.;Iván Vollmer.;Isabel Blanco.;Rubén San José Estepar.;Diego A Rodriguez-Chiaradía.;Manuel López-Meseguer.;Clara Martin-Ontiyuelo.;Pietro Nardelli.;Fernanda Hernandez-Gonzalez.;Adelaida Bosacoma.;Jesús Ribas.;Xavier Pomares.;Salud Santos.;María Molina-Molina.;Jacobo Sellares.;Farbod N Rahaghi.;George Washko.;Raúl San José Estepar.;Joan A Barberà.
来源: Chest. 2026年
Pulmonary vascular remodeling is implicated in the pathophysiology of pulmonary hypertension (PH) in chronic lung diseases. Computed tomography (CT) metrics of pulmonary vessels may provide insight into the impact of vessel morphology on PH severity in chronic lung diseases (CLD).

45. Sotatercept Safety and Efficacy in Intermediate-Low Risk Pulmonary Arterial Hypertension: A Pooled Analysis of PULSAR and STELLAR.

作者: Mardi Gomberg-Maitland.;H Ardeschir Ghofrani.;J Simon R Gibbs.;Marius M Hoeper.;Marc Humbert.;Vallerie V McLaughlin.;Ioana R Preston.;Rogerio Souza.;Aaron B Waxman.;Barry Miller.;Jianxin Lin.;Yaru Shi.;Loïc Perchenet.;James Strait.;Alexandra G Cornell.;David B Badesch.
来源: Chest. 2026年

46. State Variation in the Incidence of Small Cell Lung Cancer and its Association with Smoking.

作者: Kalyani Sonawane.;Ashvita Garg.;Adam H Fox.;Mariam Alexander.;Marvella E Ford.;Haluk Damgacioglu.;Ashish A Deshmukh.;Gerard A Silvestri.
来源: Chest. 2026年

47. Geography as a Determinant of Lung Transplant Access in the United States.

作者: Maryam Valapour.;Paul R Gunsalus.;Johnie Rose.;Carli J Lehr.;Samantha L Baker.;Jarrod E Dalton.
来源: Chest. 2026年
Geographic equity in access to donor lungs is a central objective of U.S. organ allocation policy. In March 2023, lung allocation transitioned from rigid donor-candidate distance thresholds to a continuous distribution framework using the Composite Allocation Score (CAS). CAS prioritizes medical urgency, projected posttransplant survival, biological compatibility, and geographic efficiency (continuous donor-candidate distance). On May 7, 2026, a policy amendment was approved that increased the influence of proximity on candidate ranking.

48. How I do it: Managing a Critically Ill Patient with Pulmonary Arterial Hypertension.

作者: Roxana Sulica.;Teresa De Marco.;Sonia Bartolome.;Jean M Elwing.;Namita Sood.
来源: Chest. 2026年
Management of critically ill patients with pulmonary hypertension (PH) presents significant clinical challenges. Regardless of the underlying etiology or chronicity of PH, superimposed acute illness can precipitate decompensated right ventricular failure (RVF) and death. Hospitalization, particularly in the intensive care unit (ICU), is associated with high mortality, with RVF serving as the direct or indirect cause in most cases. In this article we will focus on the management of acute decompensated RVF in patients with known pulmonary arterial hypertension (PAH). ICU management of the PAH patient with RVF centers on the recognition and treatment of potentially reversible precipitants for decompensation and supportive strategies to optimize right ventricular (RV) function. Key goals include maintaining adequate oxygenation and tissue perfusion, correcting electrolyte and other metabolic abnormalities, optimizing fluid balance and RV preload, enhancing RV contractility, and reducing RV afterload. Continuous monitoring of cardiac function is essential, as is identifying and treating potential complications, such as arrhythmias or acute kidney injury (AKI). When RVF persists despite maximal medical therapy, extracorporeal life support may be considered as a bridge to recovery or transplantation. In patients with advanced disease multidisciplinary discussions aligned with patient and family preferences should guide the goals of care. Integration of palliative care specialists to manage symptoms and support caregivers remains a critical component of comprehensive ICU management for patients with PAH.

49. Impact of pre-existing schizophrenia spectrum disorder on the receipt of surgery and other treatments for non-small cell lung cancer: A multicenter nationwide cohort study in Japan.

作者: Yuto Yamada.;Masaki Fujiwara.;Taisuke Ishii.;Tomone Watanabe.;Maiko Fujimori.;Naoki Nakaya.;Toshihiko Kawamura.;Koji Otsuki.;Eiki Ichihara.;Taichi Shimazu.;Shiro Hinotsu.;Yosuke Uchitomi.;Masatoshi Inagaki.
来源: Chest. 2026年
Patients with schizophrenia spectrum disorders (SSD) experience higher cancer mortality than the general population. Disparities in treatments for non-small cell lung cancer (NSCLC) among this population remain underexamined.

50. COPD Trial Evidence Comes From a Narrow Slice of the World: A Population Representativeness Analysis.

作者: Amr Youssef.;Alexandru Corlateanu.;Olga Corlateanu.;Augusta Beech.;Jørgen Vestbo.;Alexander G Mathioudakis.
来源: Chest. 2026年

51. Dietary patterns and asthma endotypes in Puerto Rican youth.

作者: Allen Joe.;Franziska J Rosser.;Kristina Gaietto.;Molin Yue.;Wei Chen.;Yueh-Ying Han.;Juan C Celedón.
来源: Chest. 2026年
Diet may influence the pathogenesis of asthma, a heterogeneous syndrome comprising unique mechanisms or endotypes. Little is known about the relation between diet and asthma endotypes in children and adolescents.

52. Natural history, treatment, survival, and causes of mortality in patients with subsolid and ground-glass nodules.

作者: Justin M Bader.;Samantha R Prince.;William de Santis.;Emma R Kane.;Lynn Tanoue.;Anna S Bader.;Justin D Blasberg.;Frank C Detterbeck.;Gavitt A Woodard.
来源: Chest. 2026年
Subsolid nodules (SSNs) and ground glass opacities (GGOs) are an increasingly common clinical problem. This unique subtype of lung adenocarcinoma poses a treatment dilemma as many can be safely monitored with radiographic observation alone and require no intervention. Improved understanding of the natural history and outcomes of patients with subsolid nodules is needed to improve clinical decision making and treatment recommendations.

53. Evolving Concepts in Pulmonary Hypertension: Implementation challenges of the current guidelines and proceedings in the US.

作者: Sandeep Sahay.;Rodolfo A Estrada.;Megan Griffiths.;Naomi Habib.;Sandhya Murthy.;Steven D Nathan.;Rachel T Sullivan.;James R Klinger.;Raymond Benza.
来源: Chest. 2026年
Pulmonary hypertension (PH) represents a pathophysiologically diverse and clinically intricate spectrum of disorders characterized by elevated pulmonary arterial pressures and progressive right ventricular dysfunction. The management of PH has evolved considerably over recent decades; these developments underscore the dynamic nature of the field and the necessity for continual reappraisal of diagnostic and therapeutic frameworks. The European Society of Cardiology and Respiratory Society (ESC/ERS) and the World Symposium on Pulmonary Hypertension (WSPH) were pivotal in addressing key PH topics, including hemodynamic definitions, disease classification, risk stratification and evolving therapeutic agents, and generating consensus-driven recommendations that shape global clinical practice.

54. Anti-C5a antibody STSA-1002 for patients with acute respiratory distress syndrome due to viral pneumonia: a phase 1b/2, multicenter, randomized, double-blind, placebo-controlled trial.

作者: Yeming Wang.;Xiaobo Huang.;Zhenshun Cheng.;Ziyi Chu.;Haibo Li.;Yongmei Zhang.;Mingyan Jiang.;Xin Gan.;Lei Li.;Xiuzhi Yang.;Zhiqiang Zhang.;Lijun Suo.;Yuping Li.;Xu Huang.;Xiaoqian Wang.;Song Yun.;Xianglong Xiang.;Zhong Li.;Bin Cao.
来源: Chest. 2026年
ARDS constitutes a major cause of mortality with limited therapeutic options.

55. Moving Beyond Responders: A Post Hoc Analysis Identifying Criteria for Chronic Cough Control.

作者: Mustafaa Wahab.;Elena Kum.;Nermin Diab.;Danica Brister.;Ana Oliveira.;Wafa Hassan.;Sue Beaudin.;Catie Stevens.;Jennifer Wattie.;Lesley Wiltshire.;Karen Howie.;Kieran Killian.;Roma Sehmi.;Gail M Gauvreau.;Paul M O'Byrne.;Imran Satia.
来源: Chest. 2026年
Minimally important differences (MIDs) often define treatment response in refractory chronic cough (RCC). However, MIDs represent the smallest change in an outcome that patients perceive as important and do not indicate whether cough has improved to a level that would be considered adequately controlled. Therefore, defining criteria for cough control may provide a complementary benchmark for evaluating treatment success.

56. Higher Respiratory Muscle Oxygen Cost of Breathing During Exercise in Heart Failure With Preserved Ejection Fraction.

作者: Tarin C Phillips.;Eric J Bruhn.;Gizem Cifci.;Barry A Borlaug.;Thomas P Olson.;Joshua R Smith.
来源: Chest. 2026年
Patients with heart failure with preserved ejection fraction (HFpEF) have pulmonary system abnormalities resulting in impaired ventilatory reserve and heightened respiratory muscle work during submaximal exercise.

57. Further genetic unravelling of persistent tachypnoea of infancy (PTI/NEHI).

作者: Christina K Rapp.;Katharina Mauss-Schwarzer.;Matthias Kappler.;Ingo Pawlita.;Stefanie Dillenhoefer.;Anna Wiemers.;Honorata Marczak.;Katarzyna Krenke.;Joanna Lange.;Patience N Eschenhagen.;Julian Warfsmann.;Lucas Miranda.;Bertram Mueller-Myhsok.;Johannes B Mueller-Reif.;Suzanne Nathan.;Susanne Haemmerling.;Nicolaus Schwerk.;Florian Stehling.;Matthias Griese.
来源: Chest. 2026年
Childhood interstitial lung diseases (chILDs) are rare, heterogeneous chronic pulmonary disorders that are often underdiagnosed due to their low prevalence and non-specific clinical presentation. Persistent tachypnea of infancy, often referred to as neuroendocrine cell hyperplasia of infancy (PTI/NEHI), is one of the most frequent forms of chILD, though its underlying etiology remains unknown.

58. Use of an anti-TSLP agent in patients with asthma and clinically significant bronchiectasis: a case series.

作者: Andrea Gramegna.;Giacomo Maruca.;Marco Caminati.;Gianluca Imeri.;Corrado Pelaia.;Mirta Cavallini.;Andrea Mastrototaro.;Elena Parazzini.;Dejan Radovanovic.;Paola Faverio.;Benedetta Bondi.;Diego Bagnasco.;Gianfranco Alicandro.;Pierachille Santus.;Michele Mondoni.;Stefano Aliberti.;Francesco Blasi.
来源: Chest. 2026年

59. Performance and Utility of the Sybil Deep Learning Model for Lung Cancer Risk Prediction in Asian High- and Low-Risk Populations.

作者: Yeon Wook Kim.;Jeongbin Oh.;Jinyong Park.;Myeongju Kim.;Dong Yeong Kim.;Ju Gang Nam.;Jong Sun Park.;Jae Ho Lee.;Choon-Taek Lee.
来源: Chest. 2026年
Sybil is a deep learning model designed to predict future lung cancer risk based on a single low-dose chest CT (LDCT) scan, facilitating a precision-based approach to lung cancer screening (LCS).

60. The Importance of Postprocessing Methods for Assessing Right Ventricular Volumes and Function in Patients With Pulmonary Hypertension: Results From the Postoperative Right Heart Remodeling in Patients With Chronic Thromboembolic Pulmonary Hypertension After Endarterectomy, or Pulmonary Arterial Hypertension After Lung Transplantation Study.

作者: Arshid Azarine.;Kianosh Kasani.;Young-Wouk Kim.;Hichem Sakhi.;Myriam Amsallem.;Laure Aubrege.;Virgile Chevance.;Alexandra Hauguel.;Marc Humbert.;Laurent Savale.;Xavier Jais.;David Montani.;Alison Marsden.;Elie Fadel.;Jerome Le Pavec.;Olaf Mercier.;François Haddad.
来源: Chest. 2026年
Right ventricular (RV) function and volumes assessment by cardiac MRI has emerged as a strong prognostic marker in patients with pulmonary hypertension (PH), but expert centers propose different thresholds, possibly explainable by methodologic differences.
共有 38879 条符合本次的查询结果, 用时 3.8467402 秒